Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration

This study develops and validates an intelligent computer system that helps doctors decide which breast cancer patients would benefit from neoadjuvant therapy — chemotherapy given before surgery to shrink the tumor — using imaging and clinical data. **You may be eligible if...** - You have been newly diagnosed with breast cancer and are being considered for treatment before surgery - You are an adult woman at least 18 years old - You are willing to have your imaging and clinical data used for this research **You may NOT be eligible if...** - You have already undergone surgery for this breast cancer - You have metastatic (stage IV) breast cancer - You decline to have your data included in the study Talk to your doctor to see if this trial is right for you.